Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Vapotherm, Inc.

Computational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Pilot Study demonstrates Vapotherm HVNI technology is more effective than standard oxygen therapy for treatment of acute asthma in children
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Reports Second Quarter 2023 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm To Report Second Quarter 2023 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Reports First Quarter 2023 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm To Report First Quarter 2023 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Announces NYSE Continued Listing Standard Notice Related to Stock Price
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Reports Fourth Quarter and Fiscal Year 2022 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Announces Closing of $23 Million Private Placement
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Announces $23 Million Private Placement
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Reports Preliminary Fourth Quarter and Full Year 2022 Results and Year-End Cash Balance
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Announces NYSE Continued Listing Standard Notice Related to Stock Price
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Announces Amendment to Debt Agreement
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Reports Third Quarter 2022 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm to Report Third Quarter 2022 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Announces Debt Amendment and NYSE Continued Listing Standard Notice
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm to Participate in the Canaccord Genuity 42nd Annual Growth Conference
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Reports Second Quarter 2022 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm to Report Second Quarter 2022 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm to Participate in the William Blair 42nd Annual Growth Stock Conference
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Reports First Quarter 2022 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm to Report First Quarter 2022 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Announces Preliminary Revenue for First Quarter of 2022 and Withdraws 2022 Annual Guidance
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Reports Fourth Quarter and Fiscal Year 2021 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm to Report Fourth Quarter and Full Year 2021 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Reports Third Quarter 2021 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm to Report Third Quarter 2021 Financial Results
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Vapotherm Increases Fiscal Year 2021 Revenue Outlook and Announces Expansion of Production Capacity
From Vapotherm, Inc.
Via Business Wire
Tickers VAPO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.